Palvella Therapeutics (PVLA) Selling, General & Administrative (2013 - 2026)
Palvella Therapeutics (PVLA) Selling, General & Administrative (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 555.10 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.47 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 101.25 Mn |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | 5.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.52 Mn |
| Dec 31, 2025 | 4.18 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Jun 30, 2025 | 4.13 Mn |
| Mar 31, 2025 | 3.80 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 775,000.00 |
| Dec 31, 2023 | -11.45 Mn |
| Sep 30, 2023 | 6.84 Mn |
| Jun 30, 2023 | 3.66 Mn |
| Mar 31, 2023 | 4.02 Mn |
| Dec 31, 2022 | 3.99 Mn |
| Sep 30, 2022 | 3.95 Mn |
| Jun 30, 2022 | 4.08 Mn |
| Mar 31, 2022 | 4.38 Mn |
| Dec 31, 2021 | 4.09 Mn |
| Sep 30, 2021 | 4.13 Mn |
| Jun 30, 2021 | 4.25 Mn |